ASPIRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aspirin, and what generic alternatives are available?
Aspirin is a drug marketed by Amneal Pharms, Ani Pharms, Barr, Chartwell Molecular, Dr Reddys, Endo Operations, Glenmark Speclt, Micro Labs, Sandoz, Sun Pharm, and Zydus Pharms. and is included in eleven NDAs.
The generic ingredient in ASPIRIN is aspirin; dipyridamole. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aspirin
A generic version of ASPIRIN was approved as aspirin; dipyridamole by BARR on August 14th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ASPIRIN?
- What are the global sales for ASPIRIN?
- What is Average Wholesale Price for ASPIRIN?
Summary for ASPIRIN
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for ASPIRIN |
| Drug Sales Revenues: | Drug sales revenues for ASPIRIN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ASPIRIN |
| DailyMed Link: | ASPIRIN at DailyMed |
Recent Clinical Trials for ASPIRIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Zunyi Medical College | Phase 4 |
| Assistance Publique Hopitaux De Marseille | N/A |
| Madras Medical College | Phase 3 |
Medical Subject Heading (MeSH) Categories for ASPIRIN
US Patents and Regulatory Information for ASPIRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 206392-001 | Mar 8, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Speclt | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 210318-001 | May 24, 2019 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Molecular | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 204552-001 | Mar 20, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Micro Labs | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 209929-001 | Aug 11, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
